<DOC>
	<DOCNO>NCT02500472</DOCNO>
	<brief_summary>This non-therapeutic , single-arm pilot clinical trial adult healthy smoker ass whether kava alter NNK metabolism human .</brief_summary>
	<brief_title>Investigation Kava Effects NNK Metabolism</brief_title>
	<detailed_description />
	<criteria>Adult ≥ 18 year Current smoker ≥ 5 cigarette daily , determine selfreport Adequate liver kidney function , define : Bilirubin , alkaline phosphatase , ALT , AST within normal limit Creatinine &lt; 1.2 Adequate hemoglobin , define hemoglobin ≥12 mg/dL men ≥11 woman . Ability willingness abstain medication dietary supplement 3 day prior kava administration , continue minimum 7 day kava administration . Topical medication inhale medication contain steroid permit . Ability willingness completely abstain alcohol consumption 3 day prior kava administration , continue minimum 7 day kava administration Ability understand investigational nature study provide inform consent Willingness take kava supplement instruct Known hepatobiliary disease impairment History gastric bypass surgery , gastric banding , bowel resection , malabsorption syndrome celiac sprue pancreatic insufficiency , condition may affect absorption kava Chronic medication use safely stop Use tobacco product cigarette ( i.e . snuff , snuz , smokeless tobacco , cigar , pipe ) Major chronic medical medical disease , include heart disease , poorly control diabetes , etc. , adjudicate principal investigator Women pregnant , intend become pregnant within 3 month study period , breastfeed Current recent ( within 12 month ) problem drug use alcohol dependence selfreport Antibiotic use within 2 month study enrollment selfreport Alcohol dependence , abuse , history dependence/abuse selfreport</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2017</verification_date>
	<keyword>Tobacco</keyword>
	<keyword>Smoking</keyword>
</DOC>